Sunday, March 3, 2024
- Advertisement -spot_img

TAG

biosimilars

Cyltezo Biosimilar Now Available in United States

Boehringer Ingelheim announced on July 1 that its adalimumab (Humira) biosimilar, adalimumab-adbm (Cyltezo) is now commercially available in the US.1 Cyltezo is the first...

Latest news

- Advertisement -spot_img